Monitoring changes in myeloid-derived suppressor cells post-embolization to identify HCC patients with high recurrence risk following liver transplantation. (April 2017) - Thevenot, P.; Nunez, K.; Wyczechowska, D.; Ochoa, A.; Cohen, A.